Baltimore Raises the Bar: City Sets Goal to Cut Overdose Deaths in Half by 2040

Baltimore is betting big on evidence-based intervention and community input. Mayor Brandon M. Scott released the city's finalized Overdose Response Strategic Plan on March 19, revising the original target upward from a 40% reduction in fatal overdoses to 50% by 2040—a goal city officials say reflects measurable progress already underway.

The updated plan comes as Baltimore prepares to deploy nearly $600 million in opioid settlement funds the city secured by taking pharmaceutical distributors and manufacturers to court rather than joining a global settlement that would have netted just $64 million. In the coming year alone, the city will allocate approximately $36 million to organizations focused on overdose reduction, harm intervention, and public education. That's in addition to $87 million already earmarked for 22 nonprofits working on the same issues.

"Today's finalized Overdose Response Strategic Plan provides a roadmap for building a healthier and safer city for every Baltimorean," Scott said in a statement. "I want to thank each and every person who contributed to this process by participating in our community engagement listening sessions and providing their feedback online."

Community Voices Shaped the Final Plan

Between the preliminary plan's release in July 2025 and this week's finalized version, the Mayor's Office of Overdose Response (BCMOOR) conducted four community listening sessions in neighborhoods disproportionately hit by the overdose crisis: Cherry Hill, Penn North, Park Heights, and East Baltimore. The city also collected feedback through an online form, allowing residents who couldn't attend in person to weigh in.

BCMOOR Director Sara Whaley told local media the goal increase reflects "positive trends" in overdose data. The city received finalized 2024 overdose fatality numbers and preliminary 2025 data between drafting and finalizing the plan—numbers strong enough to justify raising the bar.

According to Whaley and other city officials, community feedback led to concrete changes: strategies were rearranged to better reflect priorities, language was adjusted to match residents' suggestions, and the overall plan was simplified to make the city's next steps clearer to the public.

What the Money Will Fund

The strategic plan outlines a complex, multifaceted approach touching everything from immediate crisis response to long-term systemic change. Priorities include expanding naloxone availability, creating mobile treatment options, increasing support for peer-led overdose prevention programs, and investing in harm reduction infrastructure and 24/7 support services.

Baltimore's decision to litigate rather than settle globally has paid off financially. The city has reached settlements and jury awards totaling $579.9 million before legal fees and litigation cost repayment, according to city records. That figure dwarfs the $64 million the city would have received under the national settlement framework.

The scale of funding allows Baltimore to think beyond stopgap measures. Mobile treatment brings medication-assisted treatment and counseling to people where they are, reducing barriers like transportation and work schedules that often derail recovery. Peer support programs leverage lived experience to connect with people in active addiction in ways traditional clinical settings sometimes can't. And 24/7 support means someone in crisis at 2 a.m. on a Sunday has somewhere to turn besides an emergency room or the street.

Why Baltimore Went Its Own Way

Baltimore's decision to opt out of the national opioid settlement reflects both the severity of the local crisis and the city's willingness to take a legal gamble. In 2017, at the height of the so-called "second wave" of the opioid epidemic, Baltimore's Medical Examiner's Office placed refrigerated containers in the parking lot to handle the surge in overdose deaths. The city had been flooded with prescription opioids for years, then saw a catastrophic shift to heroin and eventually fentanyl.

By going to trial, Baltimore secured nearly ten times what the global settlement offered—a win that gives the city breathing room to experiment, innovate, and scale interventions that might otherwise remain pilot programs or unfunded ideas.

The national settlement, negotiated by state attorneys general, spread funds across thousands of jurisdictions. Baltimore's independent litigation meant keeping more dollars local and maintaining control over how they're spent.

The Long Game: 2040 and Beyond

A 50% reduction by 2040 is ambitious but not arbitrary. Overdose deaths don't respond to single interventions—they require sustained investment across prevention, harm reduction, treatment access, and recovery support. Fifteen years allows time for infrastructure to mature: peer networks to expand, mobile units to reach more neighborhoods, naloxone distribution to become ubiquitous, and medication-assisted treatment to shed the stigma that still keeps too many people from seeking help.

The city plans to update the strategic plan again in 2027 to reassess needs and adjust strategies based on what's working and what isn't. That built-in flexibility acknowledges that the overdose crisis evolves—fentanyl has already given way to fentanyl mixed with xylazine and other adulterants, and the drug supply will likely shift again.

Harm Reduction as Policy, Not Controversy

Baltimore's plan treats harm reduction as a public health necessity rather than a political flashpoint. That includes expanding access to sterile syringes, fentanyl test strips, and safe consumption education—interventions shown to reduce HIV and hepatitis transmission, prevent fatal overdoses, and connect people to treatment without requiring abstinence as a precondition for support.

The inclusion of harm reduction alongside treatment and recovery support reflects a growing consensus among public health experts: people who use drugs are more likely to survive and eventually pursue recovery if they're kept alive and engaged with services in the meantime.

Baltimore's approach also emphasizes housing stability, employment support, and addressing trauma—factors that often underlie substance use but fall outside traditional addiction treatment models. The $36 million in first-year funding allows the city to support comprehensive care rather than siloed interventions.

Questions Ahead

The plan's success will depend on execution. Nearly $600 million is a substantial sum, but Baltimore's overdose crisis is substantial too. The city will need to ensure funds reach the organizations and programs best positioned to deploy them effectively, avoid bureaucratic delays that leave money sitting in accounts while people die, and maintain community input as priorities shift.

Transparency will matter. Other jurisdictions that secured major opioid settlements have faced criticism when spending fell short of promises or dollars went to projects with tenuous connections to addiction treatment and prevention. Baltimore's decision to incorporate public feedback and publish regular updates suggests an awareness of that risk.

The 50% reduction goal is a benchmark, not a finish line. Even if Baltimore hits the target, hundreds of residents will still die from overdoses every year. The question is whether the infrastructure built with settlement dollars can outlast the settlement itself—whether peer networks, mobile treatment units, naloxone distribution channels, and recovery housing will survive when the opioid money runs out.

For now, Baltimore has a plan, the funding to back it, and a community that's been heard. Whether that adds up to 50% fewer overdose deaths by 2040 will be determined by what happens in neighborhoods like Cherry Hill, Penn North, Park Heights, and East Baltimore over the next fifteen years.